ProMIS Neurosciences Inc (PMN):企業の製品パイプライン分析

◆英語タイトル:ProMIS Neurosciences Inc (PMN) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME14743PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥192,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥288,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of neurodegenerative disorders. Its major products include tests functional assays. The company uses ProMIS technology, helps in predicting new disease specific epitopes on the molecular surface of misfolded proteins. Based on ProMIS technology, the company is developing antibody therapeutics and diagnostics targeting Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease. ProMIS is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ProMIS Neurosciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
ProMIS Neurosciences Inc Company Overview
ProMIS Neurosciences Inc Company Snapshot
ProMIS Neurosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
ProMIS Neurosciences Inc – Pipeline Analysis Overview
Business Description
ProMIS Neurosciences Inc – Key Facts
ProMIS Neurosciences Inc – Major Products and Services
ProMIS Neurosciences Inc Pipeline Products by Development Stage
ProMIS Neurosciences Inc Pipeline Products Overview
Antibody Test – COVID-19
Antibody Test – COVID-19 Product Overview
Companion Diagnostic Test – ALS
Companion Diagnostic Test – ALS Product Overview
Companion Diagnostic Test – Alzheimer’s Disease
Companion Diagnostic Test – Alzheimer’s Disease Product Overview
EP-vCJD Assay
EP-vCJD Assay Product Overview
NfL Test – Alzheimer’s Disease
NfL Test – Alzheimer’s Disease Product Overview
P-tau181 Test – Alzheimer’s Disease
P-tau181 Test – Alzheimer’s Disease Product Overview
ProMIS – Cancer
ProMIS – Cancer Product Overview
Screening Test – Liver Cancer
Screening Test – Liver Cancer Product Overview
Serology Test – Immunity Assessment
Serology Test – Immunity Assessment Product Overview
ProMIS Neurosciences Inc – Key Competitors
ProMIS Neurosciences Inc – Key Employees
ProMIS Neurosciences Inc – Key Employee Biographies
ProMIS Neurosciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ProMIS Neurosciences Inc, Recent Developments
Jan 12, 2021: ProMIS Neurosciences announces strategic priorities for 2021
Apr 15, 2020: ProMIS Neurosciences announces collaboration to develop serological test to assess COVID-19 immunity
Nov 14, 2019: ProMIS Neurosciences announces third quarter 2019 results
Aug 27, 2019: ProMIS Neurosciences appoints Internationally Recognized Researcher in Alzheimer’s Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board
Aug 13, 2019: ProMIS Neurosciences announces second quarter 2019 results
Jun 19, 2019: ProMIS Neurosciences appoints Renowned Parkinson’s Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
May 14, 2019: ProMIS Neurosciences announces first quarter 2019 results
Mar 15, 2019: ProMIS Neurosciences announces fiscal year 2018 annual results
Feb 21, 2019: ProMIS Neurosciences adds pharmaceutical leader Timothy Rothwell to board of advisors
Dec 17, 2018: ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
ProMIS Neurosciences Inc Pipeline Products and Ongoing Clinical Trials Overview
ProMIS Neurosciences Inc Pipeline Products by Equipment Type
ProMIS Neurosciences Inc Pipeline Products by Indication
ProMIS Neurosciences Inc, Key Facts
ProMIS Neurosciences Inc, Major Products and Services
ProMIS Neurosciences Inc Number of Pipeline Products by Development Stage
ProMIS Neurosciences Inc Pipeline Products Summary by Development Stage
Antibody Test - COVID-19 - Product Status
Antibody Test - COVID-19 - Product Description
Companion Diagnostic Test - ALS - Product Status
Companion Diagnostic Test - ALS - Product Description
Companion Diagnostic Test - Alzheimer's Disease - Product Status
Companion Diagnostic Test - Alzheimer's Disease - Product Description
EP-vCJD Assay - Product Status
EP-vCJD Assay - Product Description
NfL Test - Alzheimer's Disease - Product Status
NfL Test - Alzheimer's Disease - Product Description
P-tau181 Test - Alzheimer's Disease - Product Status
P-tau181 Test - Alzheimer's Disease - Product Description
ProMIS - Cancer - Product Status
ProMIS - Cancer - Product Description
Screening Test - Liver Cancer - Product Status
Screening Test - Liver Cancer - Product Description
Serology Test - Immunity Assessment - Product Status
Serology Test - Immunity Assessment - Product Description
ProMIS Neurosciences Inc, Key Employees
ProMIS Neurosciences Inc, Key Employee Biographies
ProMIS Neurosciences Inc, Subsidiaries
Glossary

★海外企業調査レポート[ProMIS Neurosciences Inc (PMN):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acacia Mining Plc:企業の戦略・SWOT・財務情報
    Acacia Mining Plc - Strategy, SWOT and Corporate Finance Report Summary Acacia Mining Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Penn National Gaming Inc:企業の戦略・SWOT・財務情報
    Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report Summary Penn National Gaming Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Eidgenossische Technische Hochschule Zurich-製薬・医療分野:企業M&A・提携分析
    Summary Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, bi …
  • Ultrapar Participacoes S.A.:企業の戦略・SWOT・財務分析
    Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report Summary Ultrapar Participacoes S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Ferroglobe PLC (GSM):企業の財務・戦略的SWOT分析
    Ferroglobe PLC (GSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BBB Technologies Inc:製品パイプライン分析
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company, which develops devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It develops single-drop, mobile integrated diagnostic tools for blood testing. Its lead pr …
  • PGE Polska Grupa Energetyczna SA (PGE):企業の財務・戦略的SWOT分析
    PGE Polska Grupa Energetyczna SA (PGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Energy XXI Gulf Coast Inc (EXXIQ):企業の財務・戦略的SWOT分析
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Ono Pharmaceutical Co Ltd (4528):医療機器:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Lixte Biotechnology Holdings Inc (LIXT):企業の財務・戦略的SWOT分析
    Lixte Biotechnology Holdings Inc (LIXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Israel Military Industries Ltd.:企業の戦略・SWOT・財務情報
    Israel Military Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Israel Military Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Haynes International Inc:企業の戦略・SWOT・財務分析
    Haynes International Inc - Strategy, SWOT and Corporate Finance Report Summary Haynes International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Nippon Yusen Kabushiki Kaisha (9101)-石油・ガス分野:企業M&A・提携分析
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company transporting crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes line trade, air carg …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Visa Inc:企業の戦略・SWOT・財務情報
    Visa Inc - Strategy, SWOT and Corporate Finance Report Summary Visa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Bri-Chem Corp. (BRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Bri-Chem Corp (Bri-Chem) is an oil and gas drilling fluids provider. It manufactures, blends, packs and conducts wholesale distribution of oilfield drilling, completion, stimulation and production chemical fluids. The company supplies custom blended cementing, acidizing and fracturing chemic …
  • SK Telecom Co., Ltd.:戦略・SWOT・企業財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Huishang Bank Corp Ltd:企業の戦略・SWOT・財務分析
    Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • Agfa-Gevaert NV (AGFB):企業の財務・戦略的SWOT分析
    Agfa-Gevaert NV (AGFB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆